Jamie R Wood Selected Research

Jamie R Wood Research Topics

13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2022 - 11/2006
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 08/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 08/2013
3	Dyslipidemias (Dyslipidemia) 01/2017 - 06/2011
1	Congenital Hyperinsulinism 02/2021
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Permanent Neonatal Diabetes Mellitus 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 06/2014
1	Insulin Resistance 08/2013
1	Pediatric Obesity 08/2013
1	Stroke (Strokes) 06/2011

6	Insulin (Novolin)FDA Link 01/2022 - 11/2006
4	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 05/2012
3	Hemoglobins (Hemoglobin)IBA 02/2017 - 05/2012
2	Vitamin D FDA LinkGeneric 12/2016 - 01/2009
2	LipidsIBA 07/2013 - 06/2011
1	Dihydroxyphenylalanine (Dopa)IBA 02/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	antiarrhythmic peptide (AAP)IBA 05/2015
1	AutoantibodiesIBA 06/2014
1	Short-Acting InsulinIBA 08/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 08/2013
1	Exenatide (Byetta)FDA Link 08/2013
1	Liraglutide FDA Link 08/2013
1	1,5-anhydroglucitolIBA 05/2012
1	oxidized low density lipoproteinIBA 06/2011
1	25-hydroxyvitamin DIBA 01/2009

3	Glycemic Control 01/2018 - 06/2011
2	Therapeutics 11/2013 - 08/2013
1	Occupational Therapy (Therapy, Occupational) 01/2018
1	Transition to Adult Care 02/2017
1	Injections 01/2017